康复新液氧气雾化吸入防治鼻咽癌放射性口腔黏膜反应的临床观察

摘要

目的：观察康复新液雾化吸入防治鼻咽癌患者放射性口腔黏膜反应的临床疗效。方法：将60例鼻咽癌患者随机分为治疗组和对照组。前者给予单药康复新，后者给予维生素同法氧气雾化吸入。结果：治疗组放射性口腔黏膜反应较对照组出现的晚，程度较对照组轻，且恢复也较对照组快，有统计学意义（ P ＜0.05）。结论：康复新液雾化吸入可延缓鼻咽癌患者放射性口腔炎的出现，减轻患者放射性口腔炎的程度，缩短放射性口腔炎的病程，对放疗规律完整进行起到辅助作用。%Objective:To observe the clinical effect of Kangfuxin atomization inhalation in prevention and control of radiation induced oral mucosa reaction in patients with nasopharyngeal carcinoma(NPC). Methods:Sixty patients with nasopharyngeal carcinoma were randomly divided into treatment group and control group. The former group was given Kangfuxin atomization inhalation,the latter group was given vitamin oxygen atomization inhalation. Results:The mucositis in the treatment group appear later,the degree were lighter and recover more quickly than the control group, the difference were statistically significant(P < 0. 05). Conclusion:Kangfuxin atomization inhalation can delay the onset,reduce the degree and shorten the duration of radiation induced oral mucositis in patients with nasopharyngeal carcinoma. Kangfuxin can relieve patientsˊ pain,and play a supporting role in promoting the compliance of radio-therapy.